Overview
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Status:
Completed
Completed
Trial end date:
2011-10-01
2011-10-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study was to compare compliance and efficacy of raloxifene and strontium ranelate in a group of women with postmenopausal osteoporosis.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of ValenciaTreatments:
Raloxifene Hydrochloride
Strontium ranelate
Criteria
Inclusion Criteria:- Postmenopausal women with densitometric osteoporosis
Exclusion Criteria:
- Secondary osteoporosis